Rxcurve
HCPCS Q9992 · per Greater than 100 MG

Buprenorphine xr over 100 mg

Products billed under this code include Sublocade.

Payment limit per Greater than 100 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under Q9992

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Sublocade Indivior Inc. 12496-0300-01 1 $2,060.132

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $2,060.132 −$8.023 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted September 17, 2026
3Q26 $2,068.155 +$71.598 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted September 15, 2026
2Q26 $1,996.557 −$1.976 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted September 15, 2026
1Q26 $1,998.533 −$17.89 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted September 15, 2026
4Q25 $2,016.423 +$39.871 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted September 8, 2026
3Q25 $1,976.552 +$51.321 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted March 10, 2026
2Q25 $1,925.231 −$6.581 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted March 10, 2026
1Q25 $1,931.812 −$11.246 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted December 19, 2025
4Q24 $1,943.058 −$18.501 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted June 11, 2025
3Q24 $1,961.559 +$86.657 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted June 11, 2025
2Q24 $1,874.902 −$12.211 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted March 11, 2025
1Q24 $1,887.113 +$0.136 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted December 19, 2024
4Q23 $1,886.977 +$0.61 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted October 10, 2024
3Q23 $1,886.367 +$92.52 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted June 5, 2024
2Q23 $1,793.847 −$31.986 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted February 23, 2024
1Q23 $1,825.833 −$16.343 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted December 6, 2023
4Q22 $1,842.176 −$16.434 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted June 22, 2023
3Q22 $1,858.61 +$77.301 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted June 9, 2023
2Q22 $1,781.309 −$5.723 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted December 14, 2022
1Q22 $1,787.032 −$9.766 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted June 8, 2022
4Q21 $1,796.798 −$19.853 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted June 2, 2022
3Q21 $1,816.651 +$80.111 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted June 2, 2022
2Q21 $1,736.54 −$0.717 Greater than 100 MG Buprenorphine xr over 100 mg v1, posted March 1, 2022
1Q21 $1,737.257 – Greater than 100 MG Buprenorphine xr over 100 mg v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files